Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX
· Real-Time Price · USD
0.80
0.00 (0.13%)
At close: Aug 15, 2025, 3:59 PM
0.82
2.44%
After-hours: Aug 15, 2025, 04:00 PM EDT
Lexaria Bioscience Income Statement
Financials in USD. Fiscal
year is
September - August.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 |
Revenue | 174K | 174K | 183.92K | 84K | 84K | 145K | 151.28K | -3.43K | 93.15K | 20.02K | 101.48K | 111.15K | 99.72K | 30.65K | 13.88K | 31.02K | 204.06K | 192.01K | 295.66K |
Cost of Revenue | n/a | n/a | 2.72K | n/a | n/a | 15.93K | 4.82K | 3.43K | 12.75K | 2.96K | 15.79K | 41.25K | 18.64K | 6.39K | 5.57K | 20.31K | 59.99K | 30.57K | 64.48K |
Gross Profit | 174K | 174K | 181.2K | 84K | 84K | 129.07K | 146.46K | -6.87K | 80.4K | 17.07K | 85.68K | 69.9K | 81.08K | 24.26K | 8.31K | 10.71K | 144.07K | 161.44K | 231.18K |
Operating Income | -3.75M | -2.75M | -2.69M | -2.2M | -1.74M | -668K | -1.14M | -1.07M | -2.38M | -1.32M | -1.77M | -1.51M | -2.42M | -1.45M | -1.99M | -1.43M | -2.5M | -2.49M | -723.77K |
Interest Income | 190.00 | n/a | 11.00 | 6.99K | n/a | n/a | 7.32K | 43.19K | 15.44K | 14.99K | 3.74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -3.79M | -2.71M | -2.7M | -2.19M | -1.78M | -652.73K | -1.19M | -1.25M | -2.38M | -1.31M | -1.77M | -1.51M | -2.42M | -1.45M | -2M | -1.3M | -2.57M | 418.19K | -713.12K |
Net Income | -3.79M | -2.71M | -2.7M | -2.18M | -1.78M | -649.54K | -1.18M | -1.24M | -2.37M | -1.3M | -1.76M | -1.47M | -2.38M | -1.43M | -1.99M | -1.18M | -2.56M | 404.11K | -696.03K |
Selling & General & Admin | 1.21M | 1.24M | 918.69K | 1.32M | 1.25M | 551.29K | 711.11K | 566.67K | 823.32K | 644.51K | 1.03M | 1.23M | 1.75M | 1.2M | 1.55M | 1.08M | 2.16M | 994.54K | 734.75K |
Research & Development | 2.72M | 1.69M | 1.95M | 967.21K | 573.09K | 245.78K | 574.49K | 500.41K | 1.64M | 696.18K | 829.49K | 356.19K | 752.1K | 275.69K | 458.71K | 439.79K | 454.44K | 176.4K | 192.26K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -83.79K | 27.93K | 27.93K | 27.93K |
Operating Expenses | 3.92M | 2.93M | 2.87M | 2.29M | 1.83M | 797.07K | 1.29M | 1.07M | 2.46M | 1.34M | 1.85M | 1.58M | 2.5M | 1.47M | 2.01M | 1.44M | 2.64M | 1.2M | 954.94K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -15.93K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -410.27K | 325.5K | 56.87K | 27.91K |
Cost & Expenses | n/a | 2.93M | 2.87M | 2.29M | 1.83M | 813K | 1.29M | 1.07M | 2.48M | 1.34M | 1.87M | 1.62M | 2.52M | 1.48M | 2.02M | 1.46M | 2.7M | 1.23M | 1.02M |
Income Tax Expense | n/a | 3.76K | n/a | n/a | n/a | -3.19K | n/a | -9.7K | -12.06K | n/a | -13.36K | n/a | n/a | n/a | n/a | -250.87K | 60.3K | -2.9M | -27.74K |
Shares Outstanding (Basic) | 18.3M | 17.51M | 16.67M | 13.12M | 13.86M | 10.77M | 9.05M | 6.61M | 6.44M | 5.95M | 5.95M | 5.89M | 5.95M | 5.91M | 5.73M | 5.1M | 5.1M | 4.05M | 3M |
Shares Outstanding (Diluted) | 18.3M | 17.51M | 16.67M | 13.12M | 13.86M | 10.77M | 9.05M | 6.61M | 6.44M | 5.95M | 5.95M | 5.89M | 5.95M | 5.91M | 5.73M | 5.1M | 5.1M | 4.05M | 3M |
EPS (Basic) | -0.21 | -0.15 | -0.16 | -0.17 | -0.13 | -0.06 | -0.13 | -0.19 | -0.37 | -0.22 | -0.3 | -0.25 | -0.4 | -0.24 | -0.35 | -0.23 | -0.5 | 0.09 | -0.23 |
EPS (Diluted) | -0.21 | -0.15 | -0.16 | -0.17 | -0.13 | -0.06 | -0.13 | -0.19 | -0.37 | -0.22 | -0.3 | -0.25 | -0.4 | -0.24 | -0.35 | -0.23 | -0.5 | 0.09 | -0.23 |
EBITDA | -3.75M | -2.75M | -2.69M | -2.2M | -1.73M | -636.8K | -1.11M | -999.58K | -2.38M | -1.3M | -1.67M | -1.47M | -2.39M | -1.42M | -1.98M | -1.27M | -2.53M | 455K | -685.19K |
EBIT | n/a | -2.75M | -2.69M | -2.15M | -1.74M | -652.73K | -1.14M | -1.07M | -2.4M | -1.32M | -1.7M | -1.51M | -2.42M | -1.45M | -2M | -1.43M | -2.57M | -1.1M | -713.12K |
Depreciation & Amortization | n/a | n/a | n/a | -7.76K | 15.07K | 15.93K | 39.66K | 70.93K | 37.26K | 24.73K | 37.27K | 38.98K | 33.79K | 36.61K | 37.55K | 37.15K | 36.98K | 36.82K | 27.93K |